Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands.

Luttjeboer, Jos

Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands. [electronic resource] - Vaccine 12 2016 - 6381-6387 p. digital

Publication Type: Journal Article

1873-2518

10.1016/j.vaccine.2016.10.019 doi


Adult
Aged
Aged, 80 and over
Cohort Studies
Cost-Benefit Analysis
Female
Human papillomavirus 16--isolation & purification
Human papillomavirus 18--isolation & purification
Humans
Middle Aged
Models, Statistical
Netherlands--epidemiology
Papillomavirus Infections--economics
Papillomavirus Vaccines--administration & dosage
Quality-Adjusted Life Years
Uterine Cervical Dysplasia--economics